Pharmacists have unique training and expertise in the appropriate use of medications and provide a wide array of patient care services in many different practice settings. These services reduce adverse drug events, improve patient safety, and optimize medication use and health outcomes. Pharmacists contribute to improving patients’ health by providing patient care services as authorized under their scope of practice and facilitated by collaborative practice agreements (CPAs).
According to the Iowa Board of Pharmacy, a ‘collaborative practice’ means that a physician may delegate aspects of drug therapy management for the physician’s patients to an authorized pharmacist through a community practice protocol. ‘Collaborative practice’ also means that a P&T committee may authorize hospital pharmacists to perform drug therapy management for inpatients and hospital clinic patients through a hospital practice protocol. To review the Iowa collaborative practice agreement regulations, please see Iowa Administrative Code 657.39.13 Collaborative Drug Therapy Management. Note: Current regulations only provide authority for pharmacists to enter into collaborative practice agreements with MDs and DOs.
Effective July 1, 2021, SF 296 will broaden the ability of pharmacists and other healthcare providers to enter into collaborative practice agreements (CPAs). Although the law will be effective July 1, patients can expect to see pharmacies offering these services beginning in the fall of 2021 when the Iowa Board of Pharmacy is expected to finalize rules implementing the legislation.